Use of probiotics for prevention of radiation-induced diarrhea

Tumori

Volumn 93, Issue 2, 2007, Pages 1-6

  Delia, Pietro ^a   Sansotta, Giuseppe ^a   Donato, Valentino ^a   Frosina, Pasquale ^a   Salatino, Antonella ^a   Messina, Giovanna ^a   De Renzis, Costantino ^a   Famularo, Giuseppe ^b  

^a UNIVERSITY OF MESSINA   (Italy)

^b SAN CAMILLO FORLANINI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LOPERAMIDE; PLACEBO; PROBIOTIC AGENT;

CANCER; CANCER RADIOTHERAPY; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; ENTERITIS; HUMAN; MAJOR CLINICAL STUDY; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION;

BACTERIAL INFECTIONS; DIARRHEA; GASTROINTESTINAL DISEASES; HUMANS; NEOPLASMS; PREMEDICATION; PROBIOTICS; RADIOTHERAPY, ADJUVANT;

EID: 34249908112     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. Donner CS. Pathophysiology and therapy of chronic radiation-induced injury to the colon. Dig Dis 1998; 16: 253-261.
2. Valls A, Pestchen I, Prats C et al. Multicenter double-blind clinical trial comparing sucralfate vs placebo in the prevention of diarrhea secondary to pelvic irradiation. Med Clin (Barc) 1999; 113: 681-684.
3. Kneebone A, Mameghan H, Bolin T et al. Effect of oral sucralfate on late rectal injury associated with radiotherapy for prostate cancer: a double-blind, randomized trial. Int J Radiat Oncol Biol Phys 2004; 60: 1088-1097.
4. Dodd MJ, Miaskowski C, Greenspan D et al. Radiation-induced mucositis: a randomized clinical trial of micronized sucralfate versus salt and soda mouthwashes. Cancer Invest 2003; 21: 21-33.
5. Resbeut M, Marteau P, Cowen D et al. A randomized double blind placebo-controlled multicenter study of mesalazine for the prevention of acute radiation enteritis. Radiother Oncol 1997; 44: 59-63.
6. Jahraus CD, Bettenhausen D, Malik U, Sellitti M, St. Clair WH. Prevention of acute radiation-induced proctosigmoiditis by balsalazide: a randomized, double-blind, placebo controlled trial in prostate cancer. Int J Radiat Oncol Biol Phys 2005; 63: 1483-1487.
7. Kozelsky TF, Meyers GF, Sloan JA et al. Phase III double-blind study of glutamine versus placebo for the prevention of acute diarrhea in patients receiving pelvic irradiation therapy. J Clin Oncol 2003; 21: 1669-1674.
8. Yavuz MN, Yavuz AA, Aydin F, Can G, Kavgachi H. The efficacy of octreotide in the therapy of acute radiation-induced diarrea: a randomized controlled study. Int J Radiat Oncol Biol Phys 2002; 54: 195-202.
9. Martin T, Uhder K, Kurek R et al. Does prophylactic treatment with proteolytic enzymes reduce acute toxicity of adjuvant pelvic irradiation? Results of a double-blind randomized trial. Radiother Oncol 2002; 65: 17-22.
10. Kneebone A, Mameghan A, Bolin T et al. The effect of oral sucralfate on the acute proctitis associated with prostate radiotherapy: a double-blind, randomized trial. Int J Radiat Oncol Biol Phys 2001; 52: 628-635.
11. Martenson JA, Bollinger JW, Sloan JA et al. Sucralfate in the prevention of treatment-induced diarrhea in patients receiving pelvic radiation therapy: a North Central Cancer Treatment Group phase III double-blind placebo-controlled trial. J Clin Oncol 2000; 18: 1239-1245.
12. Famularo G, De Simone C, Matteuzzi D, Pirovano F. Traditional and high-potency probiotic preparations: advances, perspectives and safety of oral bacteriotherapy. Biodrugs 1999; 12: 455-470.
13. Famularo G, Mosca L, Minisola G, Trinchieri V, De Simone C. Probiotic lactobacilli: a new perspective for the treatment of inflammatory bowel disease. Curr Pharm Des 2003; 9: 1973-1980.
14. Delia P, Sansotta G, Donato V et al. Prevention of radiation-induced diarrhea with the use of VSL#3, a new high-potency probiotic preparation. Am J Gastroenterol 2002; 97: 2150-2152.
15. Urbancsek H, Kazar T, Mezes I, Neumann K. Results of a double-blind, randomized study to evaluate the efficacy and safety of Antibiophilus in patients with radiation-induced diarrhoea. Eur J Gastroenterol Hepatol 2001; 13: 391-395.
16. Zocco MA, Dal Verme LZ, Cremonini F et al. Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 2006; 23: 1567-1574.
17. Bousvaros A, Guandalini S, Baldassano RN et al. A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease. Inflamm Bowel Dis 2005; 11: 833-839.
18. Prantera C, Scribano ML, Falasco G, Andreoli A, Luzi C. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomized controlled trial with Lactobacillus GG. Gut 2002; 51: 405-409.
19. Paris F, Fuks Z, Kang A et al. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 2001; 293: 293-297